[Trial Data] nausea rates in the combination arm vs sema alone
Right, the amylin question again, but with numbers this time. I have 11 data points over 10 weeks. The pattern is consistent enough that I do not think it is chance, and boring enough that nobody is going to screenshot it, which is usually a good sign. The thing I would flag for anyone new: the effect I am describing…
CagriSema ratios in trials are fixed, do not extrapolate self-mixing
The research community is small on cagrilintide. Forum lore changes faster than data.
Respectfully this is a sample of one presented as a finding.
long-acting amylin is CagriSema, different satiety profile
Strongly agree. REDEFINE is phase 7, not final.
Yeah, amylin is doing different work than GLP-1.
research use only, no human protocols in posts